Metal chelators of Formula I and Formula II are disclosed:or a pharmaceutically acceptable salt thereof.Also disclosed are metal chelator-targeting moiety complexes, metal chelator-targeting moiety-metal conjugates, kits, and methods of their preparation and use in diagnosis and/or treatment of diseases and conditions, including, inter alia, cancer and thrombosis.